RRM1 and lung adenocarcinoma: For RRM1, some studies showed that high RRM1 expression was associated with better survival in early stage NSCLC (26) or had poor prognosis in advanced NSCLC (43) or lung adenocarcinoma (44), while another study showed that RRM1 protein expression had no significant predictive value for early NSCLC patients (45).